WEBINAR PRESENTED BY ALANIZ HEALTH
Reframing Clinical Trial Communications: Patient Engagement in a Post-DEI World
Alaniz Health Presents...
Reframing Clinical Trial Communications: Patient Engagement in a Post-DEI World
Wednesday, April 23, 2025
12 PM PST / 3 PM EST
Zoom (Registration Required)
Access On Demand After Event Date
The landscape has shifted. Now what?
With executive orders chilling the language of inclusion, researchers across the country are facing new challenges in both patient outreach and internal planning. Fear is replacing clarity—and for many, the path forward feels uncertain.
This essential conversation, hosted by Roxanne Alaniz, brings together a powerhouse panel of storytellers, researchers, and strategists to explore how we can move from restriction to resilience.
What we’ll unpack:
-
How researchers can engage diverse communities without relying on now-risky DEI language
-
Why storytelling remains the most powerful (and compliant) tool in your outreach arsenal
-
Real-world tactics for grassroots engagement and community trust-building—starting today
Meet the Experts:
-
Roxanne Alaniz, Founder & CEO, Alaniz Health (Host)
-
Anna Rogers, Healthcare journalist known for “Slashing DEI Is Going to Haunt the Future of Medicine”
-
Dr. Newman, The Buck Institute – brings deep expertise in aging research and inclusive study design, offering practical insights on effectively engaging diverse and older populations in clinical trials
-
Jennefer Sorce, Alaniz Health – translating community needs into research success
Register here.
More About The Event
Hosted by Roxanne Alaniz, CEO, Alaniz Health (LinkedIn)
Roxanne Alaniz is the founder and CEO of Alaniz Health, a digital marketing agency advancing health equity by helping healthcare organizations engage diverse communities and expand access to clinical research. With 25+ years of experience, she combines strategic insight, cultural fluency, and policy expertise to drive impact.
Under her leadership, Alaniz Health has supported major research initiatives—from Alzheimer’s studies to overdose prevention—by helping teams enroll thousands from underserved populations. Roxanne advises top researchers and public health leaders on adapting to shifting policies and securing funding in a post-DEI landscape.
She’s been honored with awards including the Netty for Multicultural Design in Healthcare and recognition as a top Latin-owned and fast-growing business in the Bay Area.
Guest Panelists:
Dr. John Newman, Professor, Buck Institute for Research on Aging (LinkedIn)
Dr. Newman is a geriatrician and researcher at UCSF and the Buck Institute, where he studies how metabolism influences aging. His lab focuses on signaling metabolites like beta-hydroxybutyrate and how interventions like fasting and exercise promote healthspan by activating cellular pathways.
Anna Rogers, Senior Science Writer and Editor (LinkedIn)
Anna Jollyette Rogers is a science writer and editor with a focus on biomedical research and clinical science. She supports NIH initiatives like the Human Genome Reference Program and brings deep experience translating complex scientific topics into accessible content for diverse audiences.
